You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Pfizer/BioNTech vaccine effective against Omicron in children five and under

According to recent clinical trial results from Pfizer and BioNTech, a third COVID-19 vaccine dose was well tolerated by children aged five and below, and most side effects were mild-to-moderate.